KeyBank National Association’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.93M | Sell |
|
|||||
|
2025
Q2 | $4.75M | Sell |
|
|||||
|
2025
Q1 | $5.92M | Buy |
|
|||||
|
2024
Q4 | $4.88M | Buy |
|
|||||
|
2024
Q3 | $5.57M | Sell |
|
|||||
|
2024
Q2 | $6.41M | Buy |
|
|||||
|
2024
Q1 | $5.44M | Sell |
|
|||||
|
2023
Q4 | $5.61M | Sell |
|
|||||
|
2023
Q3 | $5.08M | Sell |
|
|||||
|
2023
Q2 | $5.15M | Sell |
|
|||||
|
2023
Q1 | $4.64M | Sell |
|
|||||
|
2022
Q4 | $4.48M | Sell |
|
|||||
|
2022
Q3 | $4.69M | Sell |
|
|||||
|
2022
Q2 | $4.92M | Sell |
|
|||||
|
2022
Q1 | $4.81M | Sell |
|
|||||
|
2021
Q4 | $4.34M | Sell |
|
|||||
|
2021
Q3 | $4.87M | Sell |
|
|||||
|
2021
Q2 | $6.69M | Sell |
|
|||||
|
2021
Q1 | $10.1M | Sell |
|
|||||
|
2020
Q4 | $21.1M | Sell |
|
|||||
|
2020
Q3 | $34.9M | Sell |
|
|||||
|
2020
Q2 | $37.6M | Buy |
|
|||||
|
2020
Q1 | $20.7M | Buy |
|
|||||
|
2019
Q4 | $13M | Buy |
|
|||||
|
2019
Q3 | $354K | Sell |
|
|||||
|
2019
Q2 | $426K | Sell |
|
|||||
|
2019
Q1 | $430K | Sell |
|
|||||
|
2018
Q4 | $389K | Buy |
|
|||||
|
2018
Q3 | $442K | Sell |
|
|||||
|
2018
Q2 | $463K | Buy |
|
|||||
|
2018
Q1 | $374K | Buy |
|
|||||
|
2017
Q4 | $311K | Sell |
|
|||||
|
2017
Q3 | $686K | Sell |
|
|||||
|
2017
Q2 | $591K | Buy |
|
|||||
|
2017
Q1 | $476K | Sell |
|
|||||
|
2016
Q4 | $336K | Buy |
|
|||||
|
2016
Q3 | $277K | Buy |
|
|||||
|
2016
Q2 | $259K | Sell |
|
|||||
|
2016
Q1 | $251K | Sell |
|
|||||
|
2015
Q4 | $538K | Sell |
|
|||||
|
2015
Q3 | $644K | Buy |
|
|||||
|
2015
Q2 | $652K | Sell |
|
|||||
|
2015
Q1 | $1.04M | Buy |
|
|||||
|
2014
Q4 | $390K | Sell |
|
|||||
|
2014
Q3 | $375K | Sell |
|
|||||
|
2014
Q2 | $381K | Sell |
|
|||||
|
2014
Q1 | $355K | Sell |
|
|||||
|
2013
Q4 | $385K | Sell |
|
|||||
|
2013
Q3 | $734K | Buy |
|
|||||
|
2013
Q2 | $724K | Buy |
|